LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference61 articles.
1. The link between kidney disease and cancer: complications and treatment;Malyszko;Lancet,2020
2. Genomic profiling in renal cell carcinoma;Dizman;Nat. Rev. Nephrol.,2020
3. BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma;Langbein;Cancer Lett.,2022
4. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma;Motzer;N. Engl. J. Med.,2019
5. Patient-reported outcome measurement and reporting for patients with advanced renal cell carcinoma: a systematic literature review;Motzer;Eur. Urol.,2023
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical characteristics and risk stratification for late-onset herpes zoster following allogeneic hematopoietic stem cell transplantation;Cancer Letters;2024-10
2. MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1/2 activation;Cancer Letters;2024-10
3. Evaluating trophinin associated protein as a biomarker of prognosis and therapy response in renal cell carcinoma;BMC Cancer;2024-08-17
4. Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer;Cancer Letters;2024-06
5. Dissection of FOXO1-Induced LYPLAL1-DT Impeding Triple-Negative Breast Cancer Progression via Mediating hnRNPK/β-Catenin Complex;Research;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3